Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Samsara BioCapital, LLC Stock Portfolio

$646Million– No. of Holdings #39

Samsara BioCapital, LLC Performance:
2024 Q1: 6.37%YTD: 6.37%2023: 19.31%

Performance for 2024 Q1 is 6.37%, and YTD is 6.37%, and 2023 is 19.31%.

About Samsara BioCapital, LLC and 13F Hedge Fund Stock Holdings

Samsara BioCapital, LLC is a hedge fund based in PALO ALTO, CA. On 26-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Samsara BioCapital, LLC reported an equity portfolio of $646.4 Millions as of 31 Mar, 2024.

The top stock holdings of Samsara BioCapital, LLC are SRRK, , . The fund has invested 18.6% of it's portfolio in SCHOLAR ROCK HLDG CORP and 14.2% of portfolio in CARGO THERAPEUTICS INC.

The fund managers got completely rid off RAYZEBIO INC, GRAPHITE BIO INC (GRPH) and PEPGEN INC (PEPG) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX) and ARCELLX INC (ACLX). Samsara BioCapital, LLC opened new stock positions in LENZ THERAPEUTICS INC, JASPER THERAPEUTICS INC (JSPR) and ADVERUM BIOTECHNOLOGIES INC (ADVM). The fund showed a lot of confidence in some stocks as they added substantially to VTV THERAPEUTICS INC (VTVT), NKARTA INC (NKTX) and PRIME MEDICINE INC.
Samsara BioCapital, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

Samsara BioCapital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Samsara BioCapital, LLC made a return of 6.37% in the last quarter. In trailing 12 months, it's portfolio return was 39.41%.

New Buys

Ticker$ Bought
lenz therapeutics inc26,985,200
jasper therapeutics inc15,414,000
adverum biotechnologies inc4,124,160

New stocks bought by Samsara BioCapital, LLC

Additions

Ticker% Inc.
vtv therapeutics inc405
nkarta inc31.38
prime medicine inc14.88
mineralys therapeutics inc12.29

Additions to existing portfolio by Samsara BioCapital, LLC

Reductions

Ticker% Reduced
janux therapeutics inc-50.00
arcellx inc-1.48

Samsara BioCapital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
rain oncology inc-2,441,460
rayzebio inc-114,763,000
graphite bio inc-22,163,400
pepgen inc-2,970,330
science 37 holdings inc-240,300

Samsara BioCapital, LLC got rid off the above stocks

Sector Distribution

Samsara BioCapital, LLC has about 52.5% of it's holdings in Healthcare sector.

Sector%
Healthcare52.5
Others47.5

Market Cap. Distribution

Samsara BioCapital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED47.5
SMALL-CAP35.1
MID-CAP7.8
MICRO-CAP6.5
NANO-CAP3

Stocks belong to which Index?

About 41.7% of the stocks held by Samsara BioCapital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others58.3
RUSSELL 200041.7
Top 5 Winners (%)%
NUVB
nuvation bio inc
404.2 %
JANX
janux therapeutics inc
123.5 %
VTVT
vtv therapeutics inc
121.6 %
INZY
inozyme pharma inc
79.8 %
VIRX
viracta therapeutics inc
79.0 %
Top 5 Winners ($)$
NKTX
nkarta inc
13.1 M
ACLX
arcellx inc
6.4 M
JSPR
jasper therapeutics inc
5.5 M
INZY
inozyme pharma inc
5.3 M
JANX
janux therapeutics inc
4.8 M
Top 5 Losers (%)%
ALLK
allakos inc
-53.9 %
LPTX
leap therapeutics inc
-35.8 %
SYRS
syros pharmaceuticals inc
-31.3 %
TNGX
tango therapeutics inc
-19.8 %
ADVM
adverum biotechnologies inc
-12.0 %
Top 5 Losers ($)$
SRRK
scholar rock hldg corp
-7.1 M
SYRS
syros pharmaceuticals inc
-4.4 M
TNGX
tango therapeutics inc
-1.2 M
LPTX
leap therapeutics inc
-1.0 M
ADVM
adverum biotechnologies inc
-0.6 M

Samsara BioCapital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Samsara BioCapital, LLC

Samsara BioCapital, LLC has 39 stocks in it's portfolio. About 76.2% of the portfolio is in top 10 stocks. SRRK proved to be the most loss making stock for the portfolio. NKTX was the most profitable stock for Samsara BioCapital, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions